Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
Shamala Thilarajah, Associate Professor at Singapore Institute of Technology, shared on LinkedIn:
”I am so excited to share that our team has been awarded the NMRC Transition Award for NEUROACT-Stroke.
A Phase I/IIa early-phase rehabilitation trial asking a simple but important question: What is the right dose of aerobic exercise to support recovery after stroke?
While dose-finding approaches are routine in drug development, they remain relatively uncommon in rehabilitation research.
NEUROACT will combine:
- Clinical recovery outcomes
- Safety and tolerability data
- Multimodal biomarkers linked to neurorecovery
- Early-phase dose articulation methods
Importantly, the study will include stroke survivors often underrepresented in rehabilitation trials.
Very grateful for the guidance of my mentors Yong Hao Pua and Deidre De Silva.
I hope to pay this forward in the years ahead.
A special thank you to Li Khim Kwah – winning our first grant together in 2020 was a breakthrough moment that laid the foundation for this research programme.
Very fortunate to be working alongside an incredible international multidisciplinary team and lived experience partners – Leonid Churilov, Sandra A Billinger, Yee Sien Ng, Prof Tan Eng King, Prof Lo Yew Long, Kate Hayward, Torsten Rackoll, Michael Nilsson, Bibhas Chakraborty, PhD, Cindy L W Ng, Ping Liao, Joyce Lui, Wendy Leaw, Jason Ong and Prakasham Thangavelu.
Looking forward to building precise, biologically informed and inclusive approaches to stroke rehabilitation.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session